Advanced search
Publication Cover
Current Medical Research and Opinion Volume 29, 2013 - Issue 6
Submit an article Journal homepage
247
Views
10
CrossRef citations to date
0
Altmetric
Research Articles

A 6 month, prospective, observational study of PDE5 inhibitor treatment persistence and adherence in Latin American men with erectile dysfunction

Eusebio Rubio-AuriolesAsociación Mexicana para la Salud Sexual, AC (AMSSAC) Mexico CityMexico
,
Luis Antonio ReyesEli Lilly and Company Mexico CityMexico
,
Leonardo BorregalesHospital Privado Centro Medico de Caracas CaracasVenezuela
,
Carlos CairoliHospital São Lucas da Pontifícia Universidade Católica do Rio Grande do Sul (HSL-PUCRS) Porto AlegreBrazil
&
Sebastian SorsaburuLilly Research Laboratories, Eli Lilly and Company Indianapolis, INUSACorrespondence[email protected]
Pages 695-706 | Accepted 18 Mar 2013, Published online: 16 Apr 2013

Citations (10)

Keep up to date with the latest research on this topic with citation updates for this article.

Subscribe to citation updates

Read on this site (2)

Edward Kim, Allen Seftel, Evan Goldfischer, Simin Baygani & Patrick Burns. (2015) Comparative efficacy of tadalafil once daily in men with erectile dysfunction who demonstrated previous partial responses to as-needed sildenafil, tadalafil, or vardenafil. Current Medical Research and Opinion 31:2, pages 379-389.
Read now
Eusebio Rubio-Aurioles, Amr El-Meliegy, Samer Abdulwahed, Carsten Henneges, Sebastian Sorsaburu & Sirel Gurbuz. (2015) Decision tree analyses of key patient characteristics in Middle Eastern/North African and Latin American men treated with long-acting and short-acting PDE5 inhibitors for erectile dysfunction. Current Medical Research and Opinion 31:2, pages 367-378.
Read now

Articles from other publishers (8)

Müslim Dogan Değer & Serdar Madendere. (2021) Erectile dysfunction treatment with Phosphodiesterase-5 Inhibitors: Google trends analysis of last 10 years and COVID-19 pandemic. Archivio Italiano di Urologia e Andrologia 93:3, pages 361-365.
Crossref
Paul Williams, Hayley McBain, Aliya Amirova, Stanton Newman & Kathleen Mulligan. (2020) Men’s beliefs about treatment for erectile dysfunction—what influences treatment use? A systematic review. International Journal of Impotence Research 33:1, pages 16-42.
Crossref
Ilan Gruenwald, Avner Spector, Tamar Shultz, Daniel Lischinsky & Eitan Kimmel. (2019) The beginning of a new era: treatment of erectile dysfunction by use of physical energies as an alternative to pharmaceuticals. International Journal of Impotence Research 31:3, pages 155-161.
Crossref
E. Baydaroglu, P. Eschwège, J. Hubert & R. El Osta. (2019) Les génériques d’inhibiteur de la 5 phosphodiestérase améliorent-ils l’observance au traitement en raison d’un coût moindre ?. Progrès en Urologie 29:6, pages 326-331.
Crossref
Dimitrios Hatzichristou, Gianluca d’Anzeo, Hartmut Porst, Jacques Buvat, Carsten Henneges, Andrea Rossi, Karim Hamidi & Hartwig Büttner. (2015) Tadalafil 5 mg once daily for the treatment of erectile dysfunction during a 6-month observational study (EDATE): impact of patient characteristics and comorbidities. BMC Urology 15:1.
Crossref
J. Buvat, D. Hatzichristou, F. G. Boess, H. Büttner, N. Gehchan, C. Henneges & H. Porst. (2014) Continuation and effectiveness of tadalafil once daily during a 6‐month observational study in erectile dysfunction: the EDATE study . International Journal of Clinical Practice 68:9, pages 1087-1099.
Crossref
Carlos Cairoli, Luis Antonio Reyes, Carsten Henneges & Sebastian Sorsaburu. (2014) PDE5 Inhibitor Treatment Persistence and Adherence in Brazilian Men: Post-hoc Analyses from a 6-Month, Prospective, Observational Study. International braz j urol 40:3, pages 390-399.
Crossref
M. G. Kirby, I. D. White, J. Butcher, B. Challacombe, J. Coe, L. Grover, P. Hegarty, G. Jackson, A. Lowndes, H. Payne, J. Rees, V. Sangar & A. Thompson. (2013) Development of UK recommendations on treatment for post‐surgical erectile dysfunction . International Journal of Clinical Practice 68:5, pages 590-608.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.